NM_000535.7(PMS2):c.448C>T (p.Pro150Ser) AND Lynch syndrome

delete

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 7, 2016
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000467711.1

Allele description

NM_000535.7(PMS2):c.448C>T (p.Pro150Ser)

Gene:

PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.1

Genomic location:

Preferred name:

NM_000535.7(PMS2):c.448C>T (p.Pro150Ser)

HGVS:

NC_000007.14:g.6002542G>A
NG_008466.1:g.11565C>T
NM_000535.7:c.448C>TMANE SELECT
NM_001322003.2:c.43C>T
NM_001322004.2:c.43C>T
NM_001322005.2:c.43C>T
NM_001322006.2:c.448C>T
NM_001322007.2:c.130C>T
NM_001322008.2:c.130C>T
NM_001322009.2:c.43C>T
NM_001322010.2:c.43C>T
NM_001322011.2:c.-437C>T
NM_001322012.2:c.-437C>T
NM_001322013.2:c.43C>T
NM_001322014.2:c.448C>T
NM_001322015.2:c.139C>T
NP_000526.2:p.Pro150Ser
NP_001308932.1:p.Pro15Ser
NP_001308933.1:p.Pro15Ser
NP_001308934.1:p.Pro15Ser
NP_001308935.1:p.Pro150Ser
NP_001308936.1:p.Pro44Ser
NP_001308937.1:p.Pro44Ser
NP_001308938.1:p.Pro15Ser
NP_001308939.1:p.Pro15Ser
NP_001308942.1:p.Pro15Ser
NP_001308943.1:p.Pro150Ser
NP_001308944.1:p.Pro47Ser
LRG_161t1:c.448C>T
LRG_161:g.11565C>T
NC_000007.13:g.6042173G>A
NM_000535.5:c.448C>T
NM_000535.6:c.448C>T
NR_136154.1:n.535C>T

Protein change:

P150S

Links:

dbSNP: rs1060503120

NCBI 1000 Genomes Browser:

rs1060503120

Molecular consequence:

NM_001322011.2:c.-437C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322012.2:c.-437C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_000535.7:c.448C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322003.2:c.43C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322004.2:c.43C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322005.2:c.43C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322006.2:c.448C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322007.2:c.130C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322008.2:c.130C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322009.2:c.43C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322010.2:c.43C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322013.2:c.43C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322014.2:c.448C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001322015.2:c.139C>T - missense variant - [Sequence Ontology: SO:0001583]
NR_136154.1:n.535C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Lynch syndrome
Identifiers:: MONDO: MONDO:0005835; MedGen: C4552100

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000551962	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Aug 7, 2016)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000551962

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Aug 7, 2016)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV000551962.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces proline with serine at codon 150 of the PMS2 protein (p.Pro150Ser). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and serine. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a PMS2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Apr 23, 2022

ClinVar

Relating variation to medicine